RecruitingEarly Phase 1NCT04649008

Localizing Epileptic Networks Using MRI and iEEG

Optimized Intracranial EEG Targeting in Focal Epilepsy Based Upon Neuroimaging Connectomics


Sponsor

University of Pennsylvania

Enrollment

290 participants

Start Date

Mar 1, 2021

Study Type

INTERVENTIONAL

Conditions

Summary

Upon successful completion of this study, the investigators expect the study's contribution to be the development of noninvasive imaging biomarkers to predict IEEG functional dynamics and epilepsy surgical outcomes. Findings from the present study may inform current and new therapies to map and alter seizure spread, and pave the way for less invasive, better- targeted, patient-specific interventions with improved surgical outcomes. This research is relevant to public health because over 20 million people worldwide suffer from focal drug-resistant epilepsy and are potential candidates for cure with epilepsy surgical interventions.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying 3T Magnetic Resonance Imaging, 7T Magnetic Resonance Imaging, and others for people with epilepsy, epilepsy intractable, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TEST3T Magnetic Resonance Imaging

Magnetic resonance imaging acquired at a field strength of 3 Tesla.

DIAGNOSTIC_TESTIntracranial electroencephalography recordings

Epilepsy patients may undergo implantation of intracranial electroencephalography (iEEG) electrodes for localization of epileptogenic foci, which also provide a means to record localized brain activity during memory or other tasks for research purposes.

DIAGNOSTIC_TEST7T Magnetic Resonance Imaging

Magnetic resonance imaging acquired at a field strength of 7 Tesla.


Locations(1)

University of Pennsylvania

Philadelphia, Pennsylvania, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04649008


Related Trials